Related Articles Why Should Phase 1 Cancer Trial Participation and Optimal End-of-Life Care Be Incompatible? Oncology. 2017;92(1):1-2 Authors: Markman M PMID: 27923224 [PubMed – indexed for MEDLINE]
Origen: Why Should Phase 1 Cancer Trial Participation and Optimal End-of-Life Care Be Incompatible? – PubMed

Related Articles Survival Following Palliative External-beam Radiotherapy of Locally Advanced and Metastatic Liver Cancer. Anticancer Res. 2017 01;37(1):203-206 Authors: Rades D, Bolm L, Schild SE, Bartscht T Abstract AIM: The goal of this study was to identify prognostic factors of survival in patients receiving palliative external-beam radiotherapy (EBRT) for advanced liver cancer. PATIENTS AND METHODS: Seventeen patients irradiated for advanced liver cancer were retrospectively evaluated. Fourteen patients had metastatic disease, three had locally advanced disease. Six variables were investigated for survival: age at EBRT, time from liver cancer diagnosis to EBRT, number of involved metastatic sites, gender, Eastern Cooperative Oncology…
Origen: Survival Following Palliative External-beam Radiotherapy of Locally Advanced and Metastatic Liver Cancer. – PubMed

Related Articles Objective Predictive Score as a Feasible Biomarker for Short-term Survival in TerminalIy Ill Patients with Cancer. Anticancer Res. 2017 01;37(1):267-275 Authors: Okugawa Y, Shirai Y, Nodono H, Matsutani F, Itoh M, Hishida A, Morimoto Y, Nishikawa R, Yokoe T, Tanaka K, Urata H, Toiyama Y, Araki T, Inoue Y, Tanaka M, Kusunoki M, Miki C Abstract BACKGROUND: In palliative care, prediction of life expectancy is one of the most crucial issues for patients, family and medical staff, in order to provide appropriate end-of-life care. The aim of this study was to formulate a new objective score to predict…
Origen: Objective Predictive Score as a Feasible Biomarker for Short-term Survival in TerminalIy Ill Patients with Cancer. – PubMed